<DOC>
	<DOCNO>NCT01375933</DOCNO>
	<brief_summary>The purpose study assess comparability phase 3 lot single commercial lot NicVAX healthy smoker .</brief_summary>
	<brief_title>A Comparability Study Phase 3 Lot Single Commercial Lot NicVAX Healthy Adult Smokers</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy male female smoker , age 1855 , currently smoke least 10 cigarette per day . Prior exposure NicVAX nicotine vaccine . History clinically significant allergic reaction . Use systemic steroid . Cancer cancer treatment within 5 year . HIV infection . History drug alcohol abuse dependence . Required treatment depression within past 12 month . Body mass index â‰¥ 30 [ calculate weight ( kg ) /height2 ( ) ] . Significant cardiovascular , hepatic , renal , psychiatric and/or respiratory disease . Inability fulfill visit approximately 30 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Smoking</keyword>
	<keyword>NicVAX</keyword>
	<keyword>Smoking vaccine</keyword>
</DOC>